RACHEL EDQUILANG: Open Payments
NPI 1730899600 · LOS GATOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 37 payments from 12 companies in 2025. Trend: 2023 $847 · 2024 $1,269 · 2025 $891
Food & beverage: $821Education: $70
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $181 |
| PFIZER INC. | 8 | $148 |
| Lilly USA, LLC | 4 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| ABBVIE INC. | 3 | $67 |
| Amgen Inc. | 2 | $59 |
| Exact Sciences Corporation | 2 | $55 |
| Bausch Health US, LLC | 1 | $21 |
Products named: Veozah, NURTEC ODT, MOUNJARO, JARDIANCE, Kerendia, FARXIGA, QULIPTA, PAXLOVID.
Industry payments across CA — which companies pay providers there.
